Abdominosacral resection: Long-term outcome in 86 patients with locally advanced or locally recurrent rectal cancer

被引:21
作者
Bosman, S. J. [1 ]
Vermeer, T. A. [1 ]
Dudink, R. L. [2 ]
de Hingh, I. H. J. T. [1 ]
Nieuwenhuijzen, G. A. P. [1 ]
Rutten, H. J. T. [1 ,3 ]
机构
[1] Catharina Hosp, Dept Colorectal Surg, NL-5602 ZA Eindhoven, Netherlands
[2] Catharina Hosp, Dept Intens Care, NL-5602 ZA Eindhoven, Netherlands
[3] Maastricht Univ, Dept Surg, Maastricht, Netherlands
来源
EJSO | 2014年 / 40卷 / 06期
关键词
Locally advanced rectal cancer; Locally recurrent rectal cancer; Abdominosacral resection; Oncological outcome; Complications; ABDOMINAL SACRAL RESECTION; PROGNOSTIC-FACTORS; PELVIC RECURRENCE; EXCISION; COMPLICATIONS; PATTERNS;
D O I
10.1016/j.ejso.2014.02.233
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aims: The purpose of this study is to evaluate the outcome of abdorninosacral resections (ASR) in patients with locally advanced or recurrent rectal cancer. Methods: From 1994 until 2012 patients with locally advanced rectal cancer (LARC) and locally recurrent rectal cancer (LRRC) underwent a curative ASR and were enrolled in a database. The postoperative complication rates, predictive factors on oncological outcome and survival rates were registered. Results: Seventy-two patients with LRRC (mean age 63; 44 male, 28 female) and 14 patients with LARC (mean age 65; 6 male, 8 female) underwent ASR. RU resection was achieved in 37 patients with LRRC and 11 patients with LARC. Twenty-seven patients underwent an R1 resection (3 in the LARC group). Eight patients had an R2 resection, compared to no patients in the LARC group. In respectively 26 and 1 patients of the LRRC and LARC groups a grade 3 or 4 complication occurred and the 30-days mortality rate was respectively 3% and 7%. The 5-years overall survival was 28% and 24% respectively. Conclusion: En bloc radical resection remains the primary goal in the treatment of dorsally located (recurrent) rectal cancer. After thorough patient selection, ASR is a safe procedure to perform, shows acceptable morbidity rates and leads to a good oncological outcome. (c) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:699 / 705
页数:7
相关论文
共 50 条
  • [21] Extended lymphadenectomy for locally advanced and recurrent rectal cancer
    Georgiou, Panagiotis A.
    Ali, S. Mohammed
    Brown, Gina
    Rasheed, Shahnawaz
    Tekkis, Paris P.
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2017, 32 (03) : 333 - 340
  • [22] High Level Sacral Bone Resection for Locally Recurrent Rectal Cancer
    Takiguchi, Nobuo
    Uemura, Mamoru
    Kitakaze, Masatoshi
    Paku, Masakatsu
    Takeda, Mitsunobu
    Sekido, Yuki
    Hata, Tsuyoshi
    Hamabe, Atsushi
    Ogino, Takayuki
    Miyoshi, Norikatsu
    Tei, Mitsuyoshi
    Kagawa, Yoshinori
    Yamamoto, Hirofumi
    Doki, Yuichiro
    Eguchi, Hidetoshi
    ANTICANCER RESEARCH, 2023, 43 (11) : 5061 - 5066
  • [23] Short-term outcome and survival after multiorgan resection for locally advanced colo-rectal cancer. Identification of risk factors
    Bartos, Adrian
    Bartos, Dana
    Stoian, Raluca
    Szabo, Bianca
    Cioltean, Cristian
    Iancu, Ioana
    Molnar, Calin
    Al Hajjar, Nadim
    Puia, Cosmin
    Iancu, Cornel
    Breazu, Caius
    ANNALI ITALIANI DI CHIRURGIA, 2018, 89 (03) : 229 - 236
  • [24] Systematic review of classification systems for locally recurrent rectal cancer
    Rokan, Z.
    Simillis, C.
    Kontovounisios, C.
    Moran, B. J.
    Tekkis, P.
    Brown, G.
    BJS OPEN, 2021, 5 (03):
  • [25] Early FDG PET response assessment of preoperative radiochemotherapy in locally advanced rectal cancer: correlation with long-term outcome
    Avallone, Antonio
    Aloj, Luigi
    Caraco, Corradina
    Delrio, Paolo
    Pecori, Biagio
    Tatangelo, Fabiana
    Scott, Nigel
    Casaretti, Rossana
    Di Gennaro, Francesca
    Montano, Massimo
    Silvestro, Lucrezia
    Budillon, Alfredo
    Lastoria, Secondo
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 (12) : 1848 - 1857
  • [26] Oxaliplatin-containing Preoperative Therapy in Locally Advanced Rectal Cancer: Local Response, Toxicity and Long-term Outcome
    Dueland, S.
    Ree, A. H.
    Groholt, K. K.
    Saelen, M. G.
    Folkvord, S.
    Hole, K. H.
    Seierstad, T.
    Larsen, S. G.
    Giercksky, K. E.
    Wiig, J. N.
    Boye, K.
    Flatmark, K.
    CLINICAL ONCOLOGY, 2016, 28 (08) : 532 - 539
  • [27] Management of locally recurrent rectal cancer
    Davis, Bradley R.
    Schlosser, Kathryn A.
    SEMINARS IN COLON AND RECTAL SURGERY, 2019, 30 (02) : 85 - 88
  • [28] Long-term Results of the "Liver First" Approach in Patients With Locally Advanced Rectal Cancer and Synchronous Liver Metastases
    Ayez, Ninos
    Burger, Jacobus W. A.
    van der Pool, Anne E.
    Eggermont, Alexander M. M.
    Grunhagen, Dirk J.
    de Wilt, Johannes H. W.
    Verhoef, Cornelis
    DISEASES OF THE COLON & RECTUM, 2013, 56 (03) : 281 - 287
  • [29] Postchemoradiation laparoscopic resection and intraoperative electron-beam radiation boost in locally advanced rectal cancer: long-term outcomes
    Felipe A. Calvo
    Claudio V. Sole
    Javier Serrano
    Marcos Rodriguez
    Francisco Marcos
    Alberto Muñoz-Calero
    Jaime Zorrilla
    Jose A. Lopez-Baena
    Benjamin Diaz-Zorita
    Jose Luis García-Sabrido
    Emilio del Valle
    Journal of Cancer Research and Clinical Oncology, 2013, 139 : 1825 - 1833
  • [30] Results of an Aggressive Approach to Resection of Locally Recurrent Rectal Cancer
    Bryan J. Wells
    Peter Stotland
    Michael A. Ko
    Wigdan Al-Sukhni
    Jay Wunder
    Peter Ferguson
    Joan Lipa
    Linda Last
    Andrew J. Smith
    Carol J. Swallow
    Annals of Surgical Oncology, 2007, 14